Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Antib Ther ; 7(1): 37-52, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38235376

ABSTRACT

Multispecific antibodies recognize two or more epitopes located on the same or distinct targets. This added capability through protein design allows these man-made molecules to address unmet medical needs that are no longer possible with single targeting such as with monoclonal antibodies or cytokines alone. However, the approach to the development of these multispecific molecules has been met with numerous road bumps, which suggests that a new workflow for multispecific molecules is required. The investigation of the molecular basis that mediates the successful assembly of the building blocks into non-native quaternary structures will lead to the writing of a playbook for multispecifics. This is a must do if we are to design workflows that we can control and in turn predict success. Here, we reflect on the current state-of-the-art of therapeutic biologics and look at the building blocks, in terms of proteins, and tools that can be used to build the foundations of such a next-generation workflow.

2.
Nat Chem Biol ; 16(1): 77-86, 2020 01.
Article in English | MEDLINE | ID: mdl-31792443

ABSTRACT

Membrane receptors sense and transduce extracellular stimuli into intracellular signaling responses but the molecular underpinnings remain poorly understood. We report a computational approach for designing protein allosteric signaling functions. By combining molecular dynamics simulations and design calculations, the method engineers amino-acid 'microswitches' at allosteric sites that modulate receptor stability or long-range coupling, to reprogram specific signaling properties. We designed 36 dopamine D2 receptor variants, whose constitutive and ligand-induced signaling agreed well with our predictions, repurposed the D2 receptor into a serotonin biosensor and predicted the signaling effects of more than 100 known G-protein-coupled receptor (GPCR) mutations. Our results reveal the existence of distinct classes of allosteric microswitches and pathways that define an unforeseen molecular mechanism of regulation and evolution of GPCR signaling. Our approach enables the rational design of allosteric receptors with enhanced stability and function to facilitate structural characterization, and reprogram cellular signaling in synthetic biology and cell engineering applications.


Subject(s)
Protein Engineering , Receptors, Dopamine D2/chemistry , Receptors, Dopamine D2/genetics , Signal Transduction , Allosteric Regulation/drug effects , Allosteric Site , Amino Acid Motifs , Biosensing Techniques , Computer Simulation , DNA Mutational Analysis , HEK293 Cells , Humans , Inhibitory Concentration 50 , Kinetics , Ligands , Molecular Dynamics Simulation , Mutagenesis , Serotonin/chemistry , Software
SELECTION OF CITATIONS
SEARCH DETAIL
...